Original Article
Editorial Commentary
Dynamic tumor tracking for locally advanced pancreatic cancer: precision in motion
Translational Cancer Research
2026;
15
(6)
:440
.
(30 June 2026)
Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment
Translational Cancer Research
2026;
15
(6)
:441
.
(30 June 2026)
Do we need to adapt the American Joint Committee on Cancer staging system after neo-adjuvant treatment in esophageal squamous cell carcinoma?
Translational Cancer Research
2026;
15
(6)
:442
.
(30 June 2026)
Original Article
Complement system-related gene signatures implicated in the recurrence of glioma
Translational Cancer Research
2026;
15
(6)
:443
.
(30 June 2026)
The role of targeted therapy in the management of colorectal cancer liver metastases: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:444
.
(30 June 2026)
Global bibliometric analysis of TP53-mutated acute myeloid leukemia: research hotspots and evolution
Translational Cancer Research
2026;
15
(6)
:445
.
(30 June 2026)
Tumor histologic subtypes and stage impact the risk of cardiovascular diseases death in lung cancer patients after chemotherapy or radiotherapy: a population-based study
Translational Cancer Research
2026;
15
(6)
:446
.
(30 June 2026)
Bone morphogenetic protein 5 as a potential diagnostic and prognostic biomarker in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:447
.
(30 June 2026)
Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study
Translational Cancer Research
2026;
15
(6)
:448
.
(30 June 2026)
METTL16-mediated upregulation of LINC00665 inhibits the apoptosis of breast cancer via regulating miR-28-5p/GLG1 axis
Translational Cancer Research
2026;
15
(6)
:449
.
(30 June 2026)
METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer
Translational Cancer Research
2026;
15
(6)
:450
.
(30 June 2026)
DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation
Translational Cancer Research
2026;
15
(6)
:451
.
(30 June 2026)
LINC01614 favors breast cancer progression through the regulation of miR-217/FN1 and mediation in PI3K/AKT signal pathway
Translational Cancer Research
2026;
15
(6)
:452
.
(30 June 2026)
A LASSO-based nomogram for predicting breast cancer-specific survival in elderly patients after surgery: a large retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:453
.
(30 June 2026)
CSN3 promotes gastric cancer progression and is associated with immune infiltration and inflammatory signaling
Translational Cancer Research
2026;
15
(6)
:454
.
(30 June 2026)
Construction of a ferroptosis-related prognostic signature and identification of SRSF9 as a key biomarker in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:455
.
(30 June 2026)
Combinatorial post-translational modification reprogramming of the endomembrane system in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:456
.
(30 June 2026)
Treatment strategies and survival outcomes of vestibular schwannoma: a comparative study based on Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2026;
15
(6)
:457
.
(30 June 2026)
Development and validation of a DYX1C1- and GNAI1-based nomogram for predicting relapse in HER2-positive breast cancer treated with trastuzumab
Translational Cancer Research
2026;
15
(6)
:458
.
(30 June 2026)
CLCA1 as an immune prognostic biomarker and therapeutic target in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:459
.
(30 June 2026)
Development and validation of an interpretable model based on ultrasound radiomics for predicting Ki-67 expression levels in breast cancer
Translational Cancer Research
2026;
15
(6)
:460
.
(30 June 2026)
Artificial intelligence-based models for colorectal cancer diagnosis using laboratory tests: an exploratory retrospective case-control study
Translational Cancer Research
2026;
15
(6)
:461
.
(30 June 2026)
Effects of different drugs on radiation-induced oral mucositis in patients with head and neck tumors: a systematic review and a network meta-analysis
Translational Cancer Research
2026;
15
(6)
:462
.
(30 June 2026)
Identification of GADD45B, HMGB3, LMNB2, and MFAP5 as lactylation-related prognostic markers for survival prediction in esophageal cancer
Translational Cancer Research
2026;
15
(6)
:463
.
(30 June 2026)
Development and internal validation of a SEER-based prediction model for survival in poorly and undifferentiated colorectal neuroendocrine neoplasms
Translational Cancer Research
2026;
15
(6)
:464
.
(30 June 2026)
Ailanthone as a novel AKT1 inhibitor that induces mitochondrial apoptosis and exerts anti-tumor activity in cervical cancer
Translational Cancer Research
2026;
15
(6)
:465
.
(30 June 2026)
Si Ni Powder enhances chemotherapy efficacy in sleep-deprived breast cancer via modulation of the tumor microenvironment
Translational Cancer Research
2026;
15
(6)
:466
.
(30 June 2026)
Development and validation of a Random Forest prediction model integrating clinical and ultrasound radiomics features for microvascular invasion in hepatocellular carcinoma patients: a retrospective study
Translational Cancer Research
2026;
15
(6)
:467
.
(30 June 2026)
The prognostic value of log odds of positive lymph nodes in patients with resectable locally advanced gastric cancer following neoadjuvant therapy: results from the SEER database
Translational Cancer Research
2026;
15
(6)
:468
.
(30 June 2026)
Integrative bioinformatics and experimental analysis identify S100A10 as a diagnostic and prognostic biomarker in pancreatic adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:469
.
(30 June 2026)
WAC is associated with malignant phenotypes and Wnt/β-catenin pathway activity in liver cancer cells
Translational Cancer Research
2026;
15
(6)
:470
.
(30 June 2026)
Endoplasmic reticulum stress promotes colorectal cancer proliferation by regulating autophagy via XBP1s
Translational Cancer Research
2026;
15
(6)
:471
.
(30 June 2026)
Phase separation of MARCH1 promotes rectal adenocarcinoma progression through PHLPP2 ubiquitination
Translational Cancer Research
2026;
15
(6)
:472
.
(30 June 2026)
SDF4: a novel prognostic biomarker and therapeutic target in hepatocellular carcinoma revealed by integrated multi‑omics analysis
Translational Cancer Research
2026;
15
(6)
:473
.
(30 June 2026)
KLK6 regulates ferroptosis through YAP/TAZ in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:474
.
(30 June 2026)
Survival improvement and widening social disadvantage-related disparities in osteosarcoma: a Surveillance, Epidemiology, and End Results-based retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:475
.
(30 June 2026)
Divergent roles of PRR11 and HEPACAM in pleural mesothelioma: PRR11 as a prognostic biomarker and HEPACAM as a stage-associated gene with paradoxical expression
Translational Cancer Research
2026;
15
(6)
:476
.
(30 June 2026)
Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(6)
:477
.
(30 June 2026)
Identification of exhausted CD8+ T-cell signatures for prognosis in multiple myeloma by integrated analysis of single-cell and bulk RNA-sequencing
Translational Cancer Research
2026;
15
(6)
:478
.
(30 June 2026)
The evolving landscape of early diagnosis for hepatocellular carcinoma: a bibliometric analysis of global research trends (2016–2026) based on WoSCC database
Translational Cancer Research
2026;
15
(6)
:479
.
(30 June 2026)
Integrated multi-omics analysis reveals tumor-suppressive phenotypes and associated transcriptomic remodeling upon METTL3 overexpression in A549 lung cancer cells
Translational Cancer Research
2026;
15
(6)
:480
.
(30 June 2026)
Prognostic and therapeutic implications of PSMD14 in hepatocellular carcinoma: an integrative analysis of transcriptomic and single-cell profiles
Translational Cancer Research
2026;
15
(6)
:481
.
(30 June 2026)
A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma
Translational Cancer Research
2026;
15
(6)
:482
.
(30 June 2026)
A pan-cancer functional atlas of ADH1A reveals its conserved role in the tumor microenvironment and immunity
Translational Cancer Research
2026;
15
(6)
:483
.
(30 June 2026)
A stromal-derived five-gene signature predicts gastric cancer recurrence through integrated bioinformatics and single-cell analysis
Translational Cancer Research
2026;
15
(6)
:484
.
(30 June 2026)
Risk factors for short-term survival in EGFR-mutated non-small cell lung cancer with brain metastasis and prognosis of the leptomeningeal metastasis subgroup: a retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:485
.
(30 June 2026)
Potential role of PPARGC1A in linking ulcerative colitis to colorectal cancer: a novel prognostic biomarker and therapeutic target
Translational Cancer Research
2026;
15
(6)
:486
.
(30 June 2026)
Efficacy and safety of combined RANKL and PD-1 inhibitors in bone metastases: a retrospective study
Translational Cancer Research
2026;
15
(6)
:487
.
(30 June 2026)
Multi-omics identification of an antibody dependent cellular phagocytosis related signature for hepatocellular carcinoma
Translational Cancer Research
2026;
15
(6)
:488
.
(30 June 2026)
Development and validation of a predictive model for perioperative venous thromboembolism in colorectal cancer patients based on D-dimer combined with fibrinogen levels
Translational Cancer Research
2026;
15
(6)
:489
.
(30 June 2026)
A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer
Translational Cancer Research
2026;
15
(6)
:490
.
(30 June 2026)
Association between pan-immune-inflammation value and prognosis in lung cancer patients: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:491
.
(30 June 2026)
Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials
Translational Cancer Research
2026;
15
(6)
:492
.
(30 June 2026)
Comprehensive bioinformatics analysis identifies DNA methylation signatures associated with immune evasion and predicts immunotherapy response in breast cancer
Translational Cancer Research
2026;
15
(6)
:493
.
(30 June 2026)
Predictive value of the preoperative systemic immune-inflammation index for primary chemotherapy resistance risk in patients with advanced gastric cancer
Translational Cancer Research
2026;
15
(6)
:494
.
(30 June 2026)
Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study
Translational Cancer Research
2026;
15
(6)
:495
.
(30 June 2026)
A mitochondrial function-based prognostic model for hepatocellular carcinoma uncovers MRPS15 as a key driver of tumor progression through oxidative phosphorylation
Translational Cancer Research
2026;
15
(6)
:496
.
(30 June 2026)
Spatial immune profiling of local tissues and its correlation with peripheral blood cytokines in lung squamous cell carcinoma patients with immune-related pneumonitis
Translational Cancer Research
2026;
15
(6)
:497
.
(30 June 2026)
A pneumolysin mutant (ΔA146 ply) induces pyroptosis in triple-negative and HER2-positive breast cancer cells via the Caspase-1/GSDME pathway: a potential antibody-drug conjugate payload
Translational Cancer Research
2026;
15
(6)
:498
.
(30 June 2026)
Single-cell mitophagy patterns dictate intercellular crosstalk in the tumor microenvironment to promote osteosarcoma progression
Translational Cancer Research
2026;
15
(6)
:499
.
(30 June 2026)
Tumor-derived CCL20 activates tumor-associated neutrophils, predicting good prognosis in endometrial cancer
Translational Cancer Research
2026;
15
(6)
:500
.
(30 June 2026)
Accuracy of machine learning in detecting lymph node metastasis of esophageal cancer: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:501
.
(30 June 2026)
Exosome-mediated regulation of the immune microenvironment via JAK/STAT signaling promotes pancreatic cancer progression
Translational Cancer Research
2026;
15
(6)
:502
.
(30 June 2026)
CNTN-1 regulates malignant biological behaviors of lung squamous cell carcinoma (LUSC) via the endoplasmic reticulum stress (ERS)/epithelial-mesenchymal transition (EMT) axis
Translational Cancer Research
2026;
15
(6)
:503
.
(30 June 2026)
Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study
Translational Cancer Research
2026;
15
(6)
:504
.
(30 June 2026)
Expression profiling, molecular subtyping and prognostic signature construction of chemokines and chemokine receptors in gastric cancer
Translational Cancer Research
2026;
15
(6)
:505
.
(30 June 2026)
A nomogram based on systemic inflammatory markers: development and validation for predicting postoperative overall survival in gastric cancer
Translational Cancer Research
2026;
15
(6)
:506
.
(30 June 2026)
Review Article
Mitochondrial dynamics imbalance in hepatocellular carcinoma: from molecular mechanisms to new strategies for targeted therapy
Translational Cancer Research
2026;
15
(6)
:507
.
(30 June 2026)
Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:508
.
(30 June 2026)
Micro- and nanoplastic exposure and cancer: current evidence, mechanistic pathways, and translational challenges
Translational Cancer Research
2026;
15
(6)
:509
.
(30 June 2026)
Letter to the Editor
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial
Translational Cancer Research
2026;
15
(6)
:510
.
(30 June 2026)
Erratum
Erratum: Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2-targeted microbubble-based ultrasound molecular imaging
Translational Cancer Research
2026;
15
(6)
:511
.
(30 June 2026)
Erratum: Developing a prognostic risk model based on circulating tumor cell genes to predict prognosis and provide potential therapeutic strategies in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:512
.
(30 June 2026)
Review Article
The management of brain necrosis as a result of SRS treatment for intra-cranial tumors
Published online: 28 August 2014
Meta-Analysis
Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis
Published online: 05 March 2013
Review Article
Common applications of next-generation sequencing technologies in genomic research
Published online: 05 March 2013
Original Article
Effect of fasting therapy in chemotherapy-protection and tumorsuppression: a systematic review
Published online: 28 April 2017
Biological basis of IORT
Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects
Published online: 25 February 2014
Review Articles
Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer
Published online: 26 September 2013
Review Articles
Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer
Published online: 19 June 2013
Editorial
Morphine, when used for treating patients with acute pancreatitis, could be more risky than previously suspected
Published online: 24 October 2017
Review Article
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?
Published online: 20 October 2023
Review Article
EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients
Published online: 19 January 2019
Review Article
Cancer biomarker discovery and validation
Published online: 18 June 2015
Review Articles
Tumor microenvironment and nanotherapeutics
Published online: 26 September 2013
Biological basis of IORT
Cell and molecular response to IORT treatment
Published online: 25 February 2014
Editorial
The CROSS road in neoadjuvant therapy for esophageal cancer: long-term results of CROSS trial
Published online: 29 September 2016
Review Articles
DNA damage tolerance: a double-edged sword guarding the genome
Published online: 19 June 2013
Review Articles
DNA crosslinking damage and cancer - a tale of friend and foe
Published online: 19 June 2013
Review Article
Renal cell carcinoma: the search for a reliable biomarker
Published online: 30 June 2017
Review Article
EGFR and HER2: is there a role in ovarian cancer?
Published online: 13 February 2015
Review Article
Urological complications after radiation therapy—nothing ventured, nothing gained: a Narrative Review
Published online: 26 February 2021
Review Article
Multiple keratoacanthoma centrifugum marginatum—a case report and systematic review
Published online: 30 December 2018Original Article
Review Article
Editorial
Letter to the Editor
Research Highlight
Commentary
Perspective
Letter to the Editors
Research Highlights
Original Article
The Distinguished Predictive Value of CFIm25 in Schistosomal and Non-Schistosomal Colorectal Cancer
Original Article
A Per- and Polyfluoroalkyl Substances-Based Gene Signature Links Prognosis to Immune Landscapes in Thyroid Cancer
Original Article
Machine Learning-Based Prediction of Survival in Breast Cancer Patients with Lung Metastasis: A SEER-Based Study
Original Article
ScRNA-seq and bulk RNA-seq reveal the characteristics of macrophage copper metabolism and establish a risk signature in hepatocellular carcinoma
Original Article
Predictive value of HALP score for clinical outcomes in lung cancer patients: a systematic review and meta-analysis
Editorial Commentary
The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition
Editorial Commentary
Dual target combination therapy demonstrates promise in extramedullary myeloma
Review Article
Lactate-Induced Epithelial-Mesenchymal Transition: A Metabolic Nexus in Pancreatic Cancer Metastasis
Original Article
Construction and Validation of a Beta-Hydroxybutyrylation Related Molecular Model for Predicting Prognosis of Papillary Thyroid Carcinoma
Editorial Commentary
The evolution of cancer therapeutics: from “undruggable” to “drugged”
Editorial Commentary
Next-generation sequencing-based high-risk genomic stratification in multiple myeloma
Review Article
Bergamottin: A Multitarget Natural Furanocoumarin with Promising Anticancer Potential
Original Article
A Single-Center Retrospective Study Evaluating the Efficacy of Anlotinib Plus Temozolomide for Recurrent Glioma Based on Real-World Data
Original Article
Multiple Prognostic Prediction Models for Subglottic Laryngeal Cancer Based on Machine Learning
Original Article
Garcinoic Acid Promotes Ferroptosis-Associated Growth Inhibition in Esophageal Squamous Cell Carcinoma through an MDM2-Associated Mechanism
Original Article
Prognostic Value of Gut Microbiota-Derived Metabolites in Non-Small Cell Lung Cancer: A Retrospective Cohort Study of Overall Survival
Original Article
Development and Validation of a Nomogram for Predicting Chemotherapy‑Associated Liver Injury in Breast Cancer Patients
Original Article
Integrative Analysis of HMGB3 in Esophageal Carcinoma: Expression Profile, Prognostic Significance, and Immune Microenvironment Associations
Original Article
A radiotherapy resistance–related prognostic signature predicts survival and the immune landscape in rectal cancer
Original Article
Elevated TARDBP expression correlates with an unfavorable prognosis, immune evasion, and poor immune efficacy in hepatocellular carcinoma
Original Article
Clinicopathological characteristics and prognosis of pulmonary spindle cell carcinoma: a population-based retrospective study using SEER data
Original Article
TRIM47 promotes cell viability, cell cycle progression, metabolic reprogramming, and inhibits apoptosis of glioma via the NF-B signaling pathway
Original Article
Differentiating Breast Cancer Lung Metastasis From Primary Lung Cancer Using Clinical and Computed Tomography Radiomics Features
Original Article
miR-506-5p targets MAPK7 to impede glioma growth and invasion through suppressing EMT and MMPs
Review Article
SLC16A3 links tumor metabolism to therapeutic opportunities in hepatocellular carcinoma
Original Article
Interpretable machine learning prediction of 1-year overall survival in pancreatic cancer patients aged 65 years and older
Original Article
A Weakly Supervised Deep Learning Model for OSCC Diagnosis and Lesion Highlighting in Histopathology Images
Original Article
High SRD5A2 expression is associated with poor prognosis and promotes tumor cell progression in colorectal cancer
Original Article
METTL17 promotes gastric cancer progression via inhibiting GSK-3β to activate Wnt/β-Catenin signaling
Original Article
The Impact of Age on Survival in Stage II Colon Cancer: A SEER Database Analysis Stratified by Chemotherapy Status
Original Article
A Comparative Analysis of Clinical and Sonographic Features: Cutaneous Melanoma and Melanocytic Nevi
Original Article
Feasibility study on the application of Raman spectroscopy in the diagnosis of glioma
Original Article
Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis
Original Article
PRSS1 promotes gastric cancer invasion and metastasis by induction of the epithelial-mesenchymal transition and activation of the MAPK/ERK pathway
Original Article
PLAU accelerates extracellular matrix remodeling through partial epithelial–mesenchymal transition in head and neck squamous cell carcinoma
Original Article
TRIM32 Drives Head and Neck Squamous Cell Carcinoma Progression via TP53 Suppression and Lysosomal/Autophagy Dysregulation
Original Article
